AI assistant
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2017
Jan 6, 2017
33148_dirs_2017-01-06_4904b58d-4748-49b1-b564-2c673f4046da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2017-01-04
Reporting Person: DEVON PARK BIOVENTURES LP (10% Owner)
Reporting Person: Devon Park Associates, L.P. (10% Owner)
Reporting Person: Devon Park Associates, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-04 | Common Stock | J | 3243709 | — | Disposed | 9857 | Indirect |
| 2017-01-04 | Common Stock | J | 9857 | — | Disposed | 0 | Indirect |
Footnotes
F1: Devon Park Bioventures, L.P. conducted an in-kind, pro rata distribution to its limited partners of all shares of the Issuer's common stock owned by it.
F2: Represents the beneficial ownership of shares of the Issuer's common stock held directly by Devon Park Bioventures, L.P. Devon Park Associates, LLC is the general partner of Devon Park Associates, L.P., which is the general partner of Devon Park Bioventures, L.P.
F3: Devon Park Associates, L.P. conducted an in-kind, pro rata distribution to its limited partners of all shares of the Issuer's common stock owned by it.
F4: Represents the beneficial ownership of shares of the Issuer's common stock held directly by Devon Park Associates, L.P. Devon Park Associates, LLC is the general partner of Devon Park Associates, L.P.